M. Merges

发表

Blocking of human immunodeficiency virus infection depends on cell density and viral stock age

J. Spouge, M. Dembo, P. Nara, 1991, Journal of virology.

CD90 Expression on human primary cells and elimination of contaminating fibroblasts from cell cultures

A. Bossie, M. Merges, Lynn Kisselbach, 2009, Cytotechnology.

A cytopathic infectivity assay of human immunodeficiency virus type 1 in human primary macrophages.

J. Spouge, P. Nara, M. Merges, 1996, Journal of virological methods.

Characterization of a simian human immunodeficiency virus encoding the envelope gene from the CCR5-tropic HIV-1 Ba-L.

Andrew Gibson, M. Reitz, J. Foulke, 2003, Journal of acquired immune deficiency syndromes.

Immunogenicity versus pathogenicity after anterior chamber inoculation of an acyclovir-induced double mutant of HSV-1.

J. Whittum-Hudson, H. Field, M. Merges, 1987, Current eye research.

Correlates of nontransmission in US women at high risk of human immunodeficiency virus type 1 infection through sexual exposure.

J. Skurnick, S. Vermund, D. Nixon, 2002, Journal of Infectious Diseases.

Preliminary findings of an in vitro human spleen mononuclear cell culture system for primary isolates of HIV type 1.

H. Kung, J. Goudsmit, P. Nara, 1997, AIDS Research and Human Retroviruses.

Factors underlying spontaneous inactivation and susceptibility to neutralization of human immunodeficiency virus.

J. L. Raina, J. Spouge, J. Moore, 1992, Virology.

HIV requires multiple gp120 molecules for CD4-mediated infection

J. Spouge, M. Dembo, P. Nara, 1990, Nature.

Emergence of viruses resistant to neutralization by V3-specific antibodies in experimental human immunodeficiency virus type 1 IIIB infection of chimpanzees

R. Gallo, J. Goudsmit, P. Nara, 1990, Journal of virology.

Human plasma enhances the infectivity of primary human immunodeficiency virus type 1 isolates in peripheral blood mononuclear cells and monocyte-derived macrophages

J. Spouge, P. Nara, W. Tsai, 1995, Journal of virology.

Emergence ofViruses Resistant toNeutralization byV3-Specific Antibodies inExperimental HumanImmunodeficiency VirusType1 IIIBInfection ofChimpanzees

W. Hatch, M. Merges, 1990 .

Evidence for rapid selection and deletion of HIV-1 subpopulations in vivo by V3-specific neutralizing antibody: a model of humoral-associated selection.

J. Goudsmit, P. Nara, L. Smit, 1990, Developments in biological standardization.